[Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
D000208:Acute Disease; D000818:Animals; D000974:Antibodies, Antinuclear / Q000032:analysis*; D000918:Antibody Specificity; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D002908:Chronic Disease; D003165:Complement System Proteins / Q000032:analysis*; D004247:DNA; D003882:Dermatomyositis / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006505:Hepatitis / Q000276:immunology; D006801:Humans; D008099:Liver / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D009157:Myasthenia Gravis / Q000276:immunology; D011817:Rabbits; D051381:Rats; D012595:Scleroderma, Systemic / Q000276:immunology; D012859:Sjogren's Syndrome / Q000276:immunology
D000974:Antibodies, Antinuclear; D003165:Complement System Proteins; D004247:DNA
Antikörper gegen Zellkernbestandteile und Konzentration von beta1A beim systemischen Lupus erythematosus und anderen Erkrankungen